Bravida (BRAV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Feb, 2026Executive summary
Net sales declined 2% in Q4 2025 to SEK 7,913 million, with organic growth at -3% and total annual net sales down 5%.
EBITA margin improved to 8.1% in Q4 (up from 7.5%), driven by strong performance in Denmark and Norway.
EPS increased 17% in Q4 and 16% for the full year, reaching SEK 6.02.
Cash flow from operating activities was robust, at SEK 1,161 million in Q4 and SEK 1,453 million for the year, with cash conversion at 79%.
The board proposed a dividend of SEK 3.80 per share, representing 63% of EPS.
Financial highlights
Q4 2025 net sales: SEK 7,913m (down from SEK 8,108m in Q4 2024); EBITA: SEK 641m (up from SEK 604m); full-year EBITA margin improved to 5.9%.
Order intake rose 11% in Q4 and 5% for the year, with backlog up 3% to SEK 15,325 million.
Service sales declined 3%, installation sales declined 1% in Q4.
Net debt/EBITDA was 1.1x at year-end.
Equity/assets ratio improved to 38.9%.
Outlook and guidance
Market decline has ended, with slow demand recovery expected in 2026 and 4% annual installation growth forecast.
Service demand expected to remain stable through 2026-2027.
Organic growth not expected before summer 2026; stepwise recovery anticipated in the second half.
Continued focus on margin, cost control, and selective project bidding.
Price pressure to persist until demand increases.
Latest events from Bravida
- EBITA down 17% on flat sales, but cash flow and service growth offset installation weakness.BRAV
Q3 202418 Feb 2026 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 202418 Feb 2026 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 20243 Feb 2026 - EBITA margin rose to 4.5% as profit grew despite lower sales and market uncertainty.BRAV
Q1 202517 Nov 2025 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 202513 Nov 2025 - EBITA margin rose to 5.3% and EPS increased 24% despite lower sales and challenging markets.BRAV
Q3 202524 Oct 2025